跳转至内容
Merck
CN

387A

白细胞酸性磷酸酶(TRAP)试剂盒

Kit formulated with all liquid reagents

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

UNSPSC Code:
12352106
NACRES:
NA.47
eCl@ss:
42010102
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


Quality Level

shelf life

Expiry date on the label.

IVD

for in vitro diagnostic use

dilution

(for histology)

application(s)

hematology
histology

shipped in

wet ice

storage temp.

2-8°C

Biochem/physiol Actions

外周血或骨髓制剂被固定在显微镜载玻片上。将所得薄膜在萘酚AS-BI 磷酸溶液和新鲜重氮化的 Fast Garnet GBC 溶液中培养。 该试剂盒用于显示血液、骨髓和组织接触制剂中的酸性磷酸酶和抗酒石酸酸性磷酸酶 (TRAP)。


Still not finding the right product?


仅试剂盒组分

产品编号
说明

  • Hematoxylin Solution, Gill No. 3 (kit only) 50 mL

试剂盒组分也可单独购买

产品编号
说明
化学品安全说明书 & 价格

  • Acetate Solution, 2.5 M, pH 5.2 50 mL
    化学品安全说明书

  • Citrate Solution, pH 3.6±0.1 (25 °C), 27 mM 50 mL
    化学品安全说明书

  • Fast Garnet GBC Base Solution 10 mL
    化学品安全说明书

  • Naphthol AS-BI Phosphoric Acid Solution 10 mL
    化学品安全说明书

  • Sodium nitrite solution 10 mL
    化学品安全说明书

  • Tartrate Solution 10 mL
    化学品安全说明书

signalword

Danger

Hazard Classifications

Acute Tox. 4 Oral - Carc. 1B - Eye Dam. 1 - Met. Corr. 1 - Skin Corr. 1B - STOT RE 2 Oral

target_organs

Kidney

存储类别

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

法规信息

监管及禁止进口产品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Yun Zhang et al.
Biological & pharmaceutical bulletin, 39(12), 2028-2035 (2016-12-03)
Osteolysis induced by chronic Gram-negative bacterial infection underlies many bone diseases such as osteomyelitis, septic arthritis, and periodontitis. Drugs that inhibit lipopolysaccharide (LPS)-induced osteolysis are critically needed for the prevention of bone destruction in infective bone diseases. In this study
L Wei et al.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 25(8), 2089-2096 (2014-05-09)
Recently, the use of the pharmacological agent strontium ranelate has come to prominence for the treatment of osteoporosis. While much investigation is focused on preventing disease progression, here we fabricate strontium-containing scaffolds and show that they enhance bone defect healing
Jihai Wang et al.
Frontiers in pharmacology, 9, 64-64 (2018-02-24)
Lipopolysaccharide (LPS) can induce bone loss by stimulating bone resorption. Natural compounds have great potential for the treatment of osteolytic bone diseases. Magnesium lithospermate B (MLB) plays an important role in protecting against oxidative damage and also has potential anti-inflammatory



全球贸易项目编号

货号GTIN
387A-1KT04061831967975